Daito Pharmaceutical Co., Ltd.'s total assets for Q4 2023 were ¥77.71B, an increase of 0.46% from the previous quarter. JP:4577 total liabilities were ¥25.44B for the fiscal quarter, a 0.53% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.